KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Acquisitions (2016 - 2025)

Medtronic's Acquisitions history spans 11 years, with the latest figure at $98.0 million for Q1 2025.

  • For Q1 2025, Acquisitions rose 88.46% year-over-year to $98.0 million; the TTM value through Apr 2025 reached $287.0 million, up 36.02%, while the annual FY2025 figure was $98.0 million, 53.55% down from the prior year.
  • Acquisitions for Q1 2025 was $98.0 million at Medtronic, down from $137.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $1.2 billion in Q3 2022 and bottomed at $18.0 million in Q2 2021.
  • The 5-year median for Acquisitions is $98.0 million (2025), against an average of $321.2 million.
  • The largest annual shift saw Acquisitions surged 30400.0% in 2021 before it plummeted 96.75% in 2023.
  • A 5-year view of Acquisitions shows it stood at $91.0 million in 2021, then surged by 642.86% to $676.0 million in 2022, then tumbled by 96.75% to $22.0 million in 2023, then soared by 522.73% to $137.0 million in 2024, then fell by 28.47% to $98.0 million in 2025.
  • Per Business Quant, the three most recent readings for MDT's Acquisitions are $98.0 million (Q1 2025), $137.0 million (Q2 2024), and $52.0 million (Q1 2024).